Editorial: Advances in molecular targeted therapies of urologic cancers
Front Oncol
.
2022 Oct 19:12:1062015.
doi: 10.3389/fonc.2022.1062015.
eCollection 2022.
Authors
Bianca Nitzsche
1
2
,
Michael Höpfner
1
2
Affiliations
1
Charité - Universitätsmedizin Berlin, Berlin, Germany.
2
HumboldtUniversität zu Berlin, Institute for Physiology, Berlin, Germany.
PMID:
36338677
PMCID:
PMC9632722
DOI:
10.3389/fonc.2022.1062015
No abstract available
Keywords:
bladder cancer (BCa); circRNA; kidney cancer; molecular targeted therapy; prostate cancer.
Publication types
Editorial